Synektik (SNT.WA) Stock Price

Synektik Price

GPW·CLOSED
334.60
​
Market closed

Over the last 16 years Synektik grew revenue by 22.9% annually, reaching 681.30 M PLN. Earnings per share have grown at 33.1% per year over the last 16 years. For Synektik, the net margin of 15.0% is up versus 6.5% a few years ago. At today's price the dividend yield works out to roughly 2.47%. The payout ratio is around 69% of earnings. The dividend has grown at 87.1% per year over the past 5 years. The consensus 12-month price target for Synektik is 306.10 PLN, about 8.5% below where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Synektik stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik business model & stock analysis

Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories.

Frequently asked questions about Synektik

Analysts currently set an average price target of 306.10 PLN for the Synektik stock (median: 306.10 PLN), implying -8.0 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Synektik stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Synektik to generate revenue of 936.85 M PLN and earnings per share of 27.66 PLN.

Converted at the current exchange rate, the Synektik share trades at 76.02 EUR (334.60 PLN).

The Synektik share (SNT.WA) is listed on 3 stock exchanges, including: London (0R4F.L).

The expected revenue of Synektik is 936.85 M PLN. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Synektik is 235.95 M PLN. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Synektik is currently 12.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Synektik stock.

The price-to-sales ratio (P/S) of Synektik is currently 3.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Synektik stock.

The Eulerpool Quality Score for Synektik is 8/10.

The ISIN of Synektik is PLSNKTK00019. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Synektik is SNT.WA. The ticker symbol is used to trade Synektik shares on the stock exchange.

Fair ValueTerminal
317.87 PLN
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
4.70 M PLN
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Poland
Currency
PLN
Initial public offering
Aug 9, 2011
ISIN
PLSNKTK00019
Cusip
X8852H108
Market capitalization
2.85 B PLNMid Cap
52-Week Range
PEG
-3.64
P/E ratio
P/Ee 2026
12.10
P/Ee 2027
14.76
P/Ee 2028
12.52
P/Ee 2029
12.01
P/Ee 2030
18.02
P/S
P/Se
3.05
EV/EBIT
17.90
P/B Ratio
12.81
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
38.86 %
Dividend
Dividend yield
2.47 %
Est. Dividend Yield
3.86 %
Payout Ratio
68.85 %
Dividend growth Ø5Y
78.92 %
Dividend payments per year
1
Dividend paid since
6 years
Dividend not reduced since
6 years
Dividend increased since
3 years
Dividend withholding tax
19.00 %
Last updated Oct 31, 2026, 12:13 PM

Synektik Peer Group

Synektik Ticker

LONDON · 0R4F.LWARSAW · SNT.WAWSE · SNT.WA

Synektik FIGI

SNT:PW · BBG001Y31JK8SNTPLN:EO · BBG007Q16N42SNTPLN:XH · BBG007Q16N79SNTPLN:XF · BBG007Q16N97SNTPLN:XE · BBG007Q16NC3SNTPLN:XJ · BBG007Q16ND2SNTPLN:XL · BBG007Q16NF0SNTPLN:XG · BBG007Q16NG9SNTPLN:XO · BBG007Q16NH8SNTPLN:XS · BBG007Q16NM2SNTPLN:XA · BBG007Q16NN1SNTPLN:E1 · BBG007Q16NP9

All fundamentals and in-depth analysis of Synektik

Our stock analysis for Synektik stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Synektik. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.